I agree that this site is using cookies. You can find further informations here.
X
Szarek, Michael
224  results:
Online X
Search for persons X
?
1

Time to clinical benefit with sotagliflozin in patients wit..:

Aggarwal, Rahul ; Bhatt, Deepak L. ; Szarek, Michael...
European Journal of Heart Failure.  26 (2024)  4 - p. 1093-1095 , 2024
Link: https://doi.org/10.1002/..
 
?
2

Alirocumab and cardiovascular outcomes according to sex and..:

Bittner, Vera A. ; Schwartz, Gregory G. ; Bhatt, Deepak L....
Journal of Clinical Lipidology.  , 2024
Link: https://doi.org/10.1016/..
 
?
3

Safety of the PCSK9 inhibitor alirocumab: insights from 47 ..:

Goodman, Shaun G ; Steg, Philippe Gabriel ; Szarek, Michael...
European Heart Journal - Cardiovascular Pharmacotherapy.  10 (2024)  4 - p. 342-352 , 2024
Link: https://doi.org/10.1093/..
 
?
4

Comparison of change in lipoprotein(a) mass and molar conce..:

Szarek, Michael ; Reijnders, Esther ; Steg, Ph Gabriel...
European Journal of Preventive Cardiology.  31 (2024)  10 - p. e75-e78 , 2024
Link: https://doi.org/10.1093/..
 
?
5

Sotagliflozin and Kidney Outcomes, Kidney Function, and Alb..:

Sridhar, Vikas S. ; Bhatt, Deepak L. ; Odutayo, Ayodele...
Clinical Journal of the American Society of Nephrology.  19 (2024)  5 - p. 557-564 , 2024
Link: https://doi.org/10.2215/..
 
?
6

How Generalizable Is The Soloist-whf Trial In 'Real World' ..:

Canonico, Mario Enrico ; Hsia, Judith ; Szarek, Michael..
Journal of Cardiac Failure.  30 (2024)  1 - p. 228 , 2024
Link: https://doi.org/10.1016/..
 
?
7

Lipoprotein(a) Blood Levels and Cardiovascular Risk Reducti..:

Szarek, Michael ; Bhatt, Deepak L. ; Miller, Michael...
Journal of the American College of Cardiology.  83 (2024)  16 - p. 1529-1539 , 2024
Link: https://doi.org/10.1016/..
 
?
8

Efficacy and safety of SGLT2 inhibitors with and without gl..:

Apperloo, Ellen M ; Neuen, Brendon L ; Fletcher, Robert A...
The Lancet Diabetes & Endocrinology.  12 (2024)  8 - p. 545-557 , 2024
Link: https://doi.org/10.1016/..
 
?
9

Quantitative Benefit–Risk Evaluation of Rivaroxaban in Pati..:

Yuan, Zhong ; Levitan, Bennett ; Deng, Hsiaowei...
Journal of the American Heart Association.  13 (2024)  8 - p. , 2024
Link: https://doi.org/10.1161/..
 
?
10

Relating Lipoprotein(a) Concentrations to Cardiovascular Ev..:

Szarek, Michael ; Reijnders, Esther ; Jukema, J. Wouter...
Circulation.  149 (2024)  3 - p. 192-203 , 2024
Link: https://doi.org/10.1161/..
 
?
11

Effect of Sotagliflozin on Early Mortality and Heart Failur..:

Pitt, Bertram ; Bhatt, Deepak L. ; Szarek, Michael...
JACC: Heart Failure.  11 (2023)  8 - p. 879-889 , 2023
Link: https://doi.org/10.1016/..
 
?
12

Efficacy of Sotagliflozin in Adults With Type 2 Diabetes in..:

Aggarwal, Rahul ; Bhatt, Deepak L. ; Szarek, Michael...
Journal of the American College of Cardiology.  82 (2023)  19 - p. 1842-1851 , 2023
Link: https://doi.org/10.1016/..
 
?
13

Effect of sotagliflozin on albuminuria in patients with typ..:

Cherney, David Z. I. ; Bhatt, Deepak L. ; Szarek, Michael...
Diabetes, Obesity and Metabolism.  25 (2023)  11 - p. 3410-3414 , 2023
Link: https://doi.org/10.1111/..
 
?
14

Sotagliflozin, A Dual SGLT1 And SGLT2 Inhibitor, Reduces Fi..:

Pitt, Bertram ; Szarek, Michael ; Banks, Phillip...
Journal of Cardiac Failure.  29 (2023)  4 - p. 683-684 , 2023
Link: https://doi.org/10.1016/..
 
?
15

Rivaroxaban in patients with symptomatic peripheral artery ..:

Govsyeyev, Nicholas ; Nehler, Mark ; Conte, Michael S....
European Journal of Vascular and Endovascular Surgery.  65 (2023)  4 - p. e45-e46 , 2023
Link: https://doi.org/10.1016/..
 
1-15